ArticleBrain and behavior2021

Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high-dose pharmaceutical-grade biotin (MD1003).

Nicolas Collongues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.